Kubota Pharmaceutical Holdings Co. Ltd. (4596) Press Release
Consolidated Financial Results for the Six Months Ended June 30, 2026 (under IFRS)
Earlier from Kubota Pharmaceutical
- Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use
- Revolutionary Myopia Management Technology Expands Across Asia -- Kubota Glass Makes Global Debut at ASEAN International Optics Fair Bangkok 2025
- Kubota Pharmaceutical Group Launches Its Unique Kubota Glass Technology Aiming to Revolutionize Myopia Management
- Kubota Pharmaceutical: Summary of Financial Results for the second quarter 2021